Mylan gets FDA nod on generic Zoloft |
|
|
|
Published
:
Tue, 06 Feb 2007 21:01 |
PITTSBURGH (AFX) - Mylan Laboratories Inc. said Tuesday it received Food and Drug Administration approval for its generic version of Pfizer Inc's antidepressant Zoloft.Pfizer recently lost patent protection on the drug. Zoloft sales fell 79 percent for Pfizer during its fourth-quarter to $166 million from $808 million a year prior.Mylan said its generic, Sertraline Hydrochloride Tablets, at doses of 25mg, 50mg and 100mg, will be shipped immediately.Shares of Mylan fell 4 cents to $22.36 on the New York Stock Exchange in afternoon trading. Shares of Pfizer rose 3 cents to $26.91 on the NYSE.Copyright 2006 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
|
|
|
|